We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Nordic Adjuvant IFN Melanoma Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01259934
Recruitment Status : Completed
First Posted : December 14, 2010
Last Update Posted : December 14, 2010
Merck Sharp & Dohme Corp.
Information provided by:
Karolinska Institutet